Wuhan, China

Xianming Hu

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Wuhan University, Yanti University. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xianming Hu. Retrieved from https://idiyas.com/inventor/xianming-hu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Xianming Hu: Innovator in Anti-Tumor Medicaments

Introduction

Xianming Hu is a notable inventor based in Wuhan, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-tumor medications. His innovative work has led to the creation of a unique compound that holds promise for cancer treatment.

Latest Patents

Xianming Hu holds a patent for a pyrazolo[1,5-A]pyrimidine derivative, which is described as a compound with potential anti-tumor properties. The patent details a general formula for this derivative and its pharmaceutically acceptable salts. The invention emphasizes the use of these compounds in the preparation of anti-tumor medicaments, showcasing Hu's commitment to advancing cancer therapies. He has 1 patent to his name.

Career Highlights

Throughout his career, Xianming Hu has been associated with prominent educational institutions, including Yantai University and Wuhan University. His work in these institutions has allowed him to engage in cutting-edge research and development in the pharmaceutical field.

Collaborations

Xianming Hu has collaborated with notable colleagues such as Xi Zhu and Mingmin Ding. These partnerships have likely contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

Xianming Hu is a distinguished inventor whose work in anti-tumor medicaments has the potential to impact cancer treatment significantly. His innovative contributions and collaborations highlight his dedication to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…